Prescriptions and Drug Coverage

The price at the pharmacy counter is rarely the only price available. The same drug can cost $600 or $35 depending on a coupon, a manufacturer program, a switch to a covered alternative, or a prior authorization the office never filed. Shortages have their own workarounds. Specialty and biologic drugs have assistance programs most patients never hear about.

These guides cover the moves that actually lower a medication cost: manufacturer copay cards and patient assistance programs, generic and therapeutic substitutions, discount cards, prior authorization and step therapy, surviving a shortage, and the coverage rules behind specialty and biologic pricing.

If a prescription is suddenly unaffordable or stuck behind a coverage rule, text Kite the drug name and it finds the paths to a lower price and the paperwork to unstick it.

11 guides in Medications

July 5, 2026·7 min read

The Pharmacy Is Out of Your ADHD Meds Again. The Survival Guide for Schedule II Shortages

Stimulants are Schedule II drugs: no refills, no easy transfers, 30-day fills. The 2023 DEA transfer rule, the call-around script, equivalent-formulation switches, and how to never hit a zero-pill day again.

July 5, 2026·8 min read

Insurance Denied Your Wegovy or Zepbound. What Actually Works Next

First find out if it's a denial or a plan exclusion; the fights differ. Covered-indication angles (diabetes, heart risk, sleep apnea), the appeal that works, Medicare's $50 GLP-1 Bridge, and real self-pay prices.

July 5, 2026·8 min read

Your Prescription Costs Too Much. Here's Every Legit Way to Pay Less

The first price at the pharmacy counter is rarely the real floor. Copay cards, patient assistance programs, discount prices, Cost Plus Drugs, Medicare's $2,100 cap and $35 insulin, and the traps to know.

July 19, 2026·7 min read

The Pharmacy Says It's Too Early to Refill. What to Do

"Refill too soon" is an insurance edit, not a wall. The overrides that work, the dose-change fix, the stricter rules for ADHD and controlled meds, and what to do the day you actually run out.

July 5, 2026·8 min read

The Diabetes Cost Stack: Insulin Caps, CGM Coverage Rules, and the Supply Denials That Reverse

Insulin is capped at $35 for most people who ask correctly, Medicare covers CGMs for anyone on insulin, and the Dexcom-denied-with-authorization pattern loses to paperwork. The whole money map for diabetes.

July 16, 2026·8 min read

Ran Out of Insulin or Can't Afford the Refill? What You Can Do Tonight

Pharmacists in most states can dispense emergency insulin, and every manufacturer sells a month for $35 same day. The tonight options ladder, plus the ER line.

July 19, 2026·7 min read

Your Dexcom, Libre, or Omnipod Failed. How to Get a Free Replacement

A failed sensor or pod is a warranty replacement, free, direct from the maker. The exact numbers, forms, and info to have ready for Dexcom, FreeStyle Libre, and Omnipod, plus what to do when they blame "user error."

July 16, 2026·8 min read

Ozempic and Mounjaro Prior Authorization for Type 2 Diabetes: What Plans Actually Check, and Why Diabetes Denials Reverse

A type 2 diabetes diagnosis changes the GLP-1 math: what prior auth actually checks, how step-therapy denials reverse, and the $25 manufacturer cards.

July 5, 2026·8 min read

Biologics Without Bankruptcy: Copay Cards, the Accumulator Trap, and the Biosimilar Lever

Humira-class drugs list at $6,000+ a month, manufacturer cards make them affordable, and 4 in 10 commercial plans quietly stop that assistance from counting toward your deductible. The full playbook, including the biosimilar switch.

July 5, 2026·7 min read

Getting the New Migraine Drugs Covered: Step Therapy, Documented Failures, and the Bridge Programs

Insurers gate Nurtec, Ubrelvy, Aimovig, and Emgality behind fail-first rules even as headache specialists call them first-line. The documentation that unlocks them, the copay bridges, and the appeal that names parity.

July 5, 2026·7 min read

Ten Prescriptions, Four Doctors, Zero Referees: How to Audit a Medication List

When every specialist adds and nobody subtracts, the med list itself becomes a health risk. The brown-bag review, Medicare's free MTM program, the questions that trigger deprescribing, and the interactions worth knowing about.

Frequently asked questions

Why is my prescription suddenly so expensive?+

Common reasons are a new plan year resetting your deductible, the drug moving to a higher formulary tier, a lost prior authorization, or a manufacturer coupon expiring. Ask the pharmacist to run it a different way, check for a covered alternative with your prescriber, and look for a manufacturer or patient assistance program.

What is step therapy and can I get around it?+

Step therapy requires you to try a cheaper drug before the plan covers the one your doctor prefers. You can request an exception if you have already tried the required drug, cannot take it for medical reasons, or it would be unsafe. Your prescriber submits the exception with documentation.

Are patient assistance programs real and worth it?+

Yes. Drug manufacturers and nonprofit foundations run programs that provide medications free or at steep discounts to people who qualify by income or need. They are legitimate and widely used, especially for insulin, specialty, and biologic drugs. The application usually takes proof of income and a prescriber signature.

Or skip the reading and just text it.

Text Kite the bill, the letter, or the result and it does the reading, the drafting, and the remembering. Free to start, no app, no account.

Text Kite Here